Praxis (PRAX) director awarded 1,371 RSUs and 648-share stock option

Rhea-AI Filing Summary

Praxis Precision Medicines director Merit Ester Cudkowicz reported equity compensation awards. She received 1,371 restricted stock units, each representing one future share of common stock. These units vest in a single installment on the earlier of June 10, 2027 or the company’s 2027 annual stockholder meeting and are settled only in shares.

She was also granted an option to buy 648 shares of common stock at an exercise price of $240.66 per share. The option vests in 12 equal monthly installments beginning July 10, 2026, with final vesting on the earlier of June 10, 2027 or the 2027 annual meeting. Following these grants, she reports 1,371 common shares and 648 options as directly owned.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Cudkowicz Merit Ester

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	648	$0.00	--
Grant/Award	Common Stock	1,371	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 648 shares (Direct, null); Common Stock — 1,371 shares (Direct, null)

Footnotes (1)

1. Dr. Cudkowicz was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.

Key Figures

RSUs granted: 1,371 units Option shares granted: 648 shares Option exercise price: $240.66 per share +3 more

6 metrics

RSUs granted 1,371 units Restricted stock units awarded to director, each for one share

Option shares granted 648 shares Stock option covering common stock

Option exercise price $240.66 per share Stock option strike price

RSU vesting date Earlier of June 10, 2027 or 2027 annual meeting Single-installment vesting trigger

Option vesting start July 10, 2026 First of 12 equal monthly installments

Option expiration June 10, 2036 Option term end date

Key Terms

restricted stock units, Stock Option (Right to Buy), vest in twelve (12) equal monthly installments, annual meeting of stockholders

4 terms

restricted stock units financial

"Dr. Cudkowicz was awarded 1,371 restricted stock units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy) ... transaction_shares": "648.0000""

vest in twelve (12) equal monthly installments financial

"The shares subject to this option shall vest in twelve (12) equal monthly installments"

annual meeting of stockholders financial

"the date of the Issuer's 2027 annual meeting of stockholders"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cudkowicz Merit Ester

(Last) (First) (Middle)

C/O PRAXIS PRECISION MEDICINES, INC.

99 HIGH STREET, 30TH FLOOR

(Street)

BOSTON MASSACHUSETTS 02110

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Praxis Precision Medicines, Inc. [ PRAX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/10/2026		A(1)		1,371	A	$0	1,371	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$240.66	06/10/2026		A		648		(2)	06/10/2036	Common Stock	648	$0	648	D

Explanation of Responses:

1. Dr. Cudkowicz was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

2. The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.

Remarks:

	/s/ Alex Nemiroff, as Attorney-in-Fact	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity awards did Praxis (PRAX) director Merit Ester Cudkowicz receive?

She received 1,371 restricted stock units and a stock option for 648 shares. The RSUs convert one-for-one into common shares, and the option allows future share purchases at a fixed $240.66 exercise price, subject to vesting.

How do the 1,371 RSUs granted to the PRAX director vest?

The 1,371 restricted stock units vest in a single annual installment. Vesting occurs on the earlier of June 10, 2027 or Praxis Precision Medicines’ 2027 annual meeting of stockholders, after which each vested unit is settled in one share of common stock.

What are the key terms of the 648-share stock option granted at Praxis (PRAX)?

The option covers 648 shares of common stock at a $240.66 exercise price and expires June 10, 2036. It vests in 12 equal monthly installments starting July 10, 2026, finishing on the earlier of June 10, 2027 or the 2027 annual meeting.

Is the Form 4 transaction for PRAX a market purchase or a compensation grant?

The Form 4 reflects compensation-related grants, not market trades. Both the 1,371 restricted stock units and the 648-share stock option are reported with transaction code “A” for grants or awards, indicating equity-based compensation to the director.

How many Praxis (PRAX) shares does Merit Ester Cudkowicz report owning after these awards?

After the awards, she reports direct ownership of 1,371 shares of common stock and a stock option covering 648 additional shares. The RSUs and option vest over time, so full economic benefit depends on continued service and vesting.

When do the PRAX director’s RSUs and options fully vest if the 2027 meeting is before June 10, 2027?

Both awards reference the earlier of June 10, 2027 or the 2027 annual meeting. If the meeting occurs earlier, the 1,371 RSUs vest then, and the final monthly installment of the 648-share option also vests by that earlier meeting date.